Investors

2014 News Releases

Keyword Search
 
2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004
September 19, 2014
Gjalt Huisman, Codexis, receives industrial biocatalysis award
View Larger Image Gjalt Huisman of Codexis was awarded the “Biocat Award 2014 for Industrial Research” for his contributions in the field of industrial biocatalysis, at biocat2014, the 7th International Congress on Biocatalysis, held from August 31st to September 4th in Hamburg, Germany.   The Biocat Awards are awarded to scientists to acknowledge their research achievements in the field of biocatalysis. The prestigious awards are presented in three categories: Scientific ... 
August 06, 2014
Codexis Reports Financial Results for the Second Quarter of 2014
Conference call today at 4:30 pm ET REDWOOD CITY, Calif., Aug. 6, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced its financial results for the second quarter ended June 30, 2014. "I am pleased to announce that Codexis is now set to deliver a positive cash flow result in 2014, well ahead of our previous expectations. After delivering results in line with our expectations in the sec... 
July 31, 2014
Codexis to Announce Second Quarter 2014 Financial Results on August 6, 2014
REDWOOD CITY, Calif., July 31, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced it will host a live conference call and audio webcast on Wednesday, August 6, 2014 at 4:30 p.m. Eastern Time to discuss its second quarter 2014 financial results. The call and webcast will follow the release of second quarter financial results after market close. A recorded version of the call will be av... 
July 28, 2014
Gordon Sangster to Join Codexis as Senior Vice President & Chief Financial Officer
REDWOOD CITY, Calif., July 28, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced that Gordon Sangster has agreed to join Codexis as Senior Vice President & Chief Financial Officer. Gordon, who will start on August 18, 2014, will manage all aspects of Codexis' financial and accounting functions and will report to John Nicols, President & Chief Executive Officer. "Gordon brings ... 
July 14, 2014
Codexis Announces Technology Collaboration and License Agreement With GSK
Codexis to Receive Up to $25 Million of Initial Payments, Plus Additional Milestone and Royalty Opportunities Codexis to Host a Conference Call on July 15, 2014 at 8:30 a.m. ET / 5:30 a.m. PT REDWOOD CITY, Calif., July 14, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced the signing of a platform technology license agreement with GlaxoSmithKline (GSK). Under the terms of the agreement... 
May 07, 2014
Codexis Reports Financial Results for the First Quarter of 2014
Conference Call today at 4:30 pm ET REDWOOD CITY, Calif., May 7, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced its financial results for the first quarter ended March 31, 2014. "Codexis is off to a solid start in 2014, now fully focused on our core strategy of growing our biocatalyst business serving pharmaceutical drug development and manufacturing," said John Nicols, President ... 
April 30, 2014
Codexis to Announce First Quarter 2014 Financial Results on May 7, 2014
REDWOOD CITY, Calif., April 30, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced it will host a live conference call and audio webcast on Wednesday, May 7, 2014 at 4:30 p.m. Eastern Time to discuss its first quarter 2014 financial results. The call and webcast will follow the release of fourth quarter financial results after market close. A recorded version of the call will be available ... 
March 13, 2014
Codexis Sells Its Hungarian Operations to Intrexon Corporation
REDWOOD CITY, Calif., March 13, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced the sale of its subsidiary in Hungary to Intrexon Corporation. The transaction closed on March 13, 2014, with a purchase price of $1.5 million. No proprietary Codexis materials or intellectual property were included in the transaction. "We are very pleased with this transaction," said John Nicols, Presid... 
March 11, 2014
Codexis Reports Fourth Quarter and Full Year 2013 Results
Conference Call Today at 4:30 pm ET REDWOOD CITY, Calif., March 11, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced its financial results for the fourth quarter and year ended December 31, 2013. "We had a strong finish in 2013 as we executed well on our restructuring plans and delivered a solid financial result in the fourth quarter in our core biocatalysts business," said John Nic... 
February 27, 2014
Codexis Appoints Biopharmaceuticals Industry Veteran, Patrick Yang, Ph.D., to Board of Directors
REDWOOD CITY, Calif., Feb. 27, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced the appointment of Patrick Yang, Ph.D., to its board of directors. Dr. Yang brings significant experience in pharmaceutical manufacturing and process development to the Codexis board, following several executive leadership roles within the pharmaceutical industry. John Nicols, President and CEO of Codexis... 
February 25, 2014
Codexis to Announce Fourth Quarter and Fiscal Year 2013 Financial Results on March 11, 2014
REDWOOD CITY, Calif., Feb. 25, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced it will host a live conference call and audio webcast on Tuesday, March 11, 2014 at 4:30 p.m. Eastern Time to discuss its fourth quarter and fiscal year 2013 financial results for the period ended December 31, 2013. The call and webcast will follow the release of fourth quarter and fiscal year financial resul... 
February 04, 2014
Codexis to Present at 16th Annual BIO CEO & Investor Conference
REDWOOD CITY, Calif., Feb. 4, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and complex chemistry industries, today announced that John Nicols, President and CEO of Codexis, will present a company overview at the 16th Annual BIO CEO & Investor Conference on Tuesday, February 11, 2014 at 1:00 p.m. ET in New York City. A live webcast and replay will be available on the Investors section of the company's website, http://ir.c... 
Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS |

Share Page

X
| E-mail Alerts E-mail Alerts | IR Contacts Contacts | Financial Tear Sheet Tear Sheet

WE ARE BIOCATALYSISTM

We are an industrial biotechnology company delivering real business results through biobased innovation in chemicals, fuels, pharmaceuticals, consumer, and industrial products.

PHARMACEUTICAL ENZYMES


Supporting faster, cleaner, more efficient pharmaceutical manufacturing processes

Codexis delivers a range of chemicals at kilogram to multi-ton scale, through a partnered manufacturing network

CODEXIS

WHAT WE DO


Codexis delivers revolutionary biocatalytic routes that no one else can


CODEXIS

MEDIA CENTER


Visit our Media Center for the latest product information, videos, imagery, technical papers and press information.


CAREERS AT CODEXIS

An opportunity to make a difference.

Continued success at Codexis depends on the innovation, collaboration and commitment of people who are passionate about what they do


CODEXIS

INVESTOR CENTER


Access to Codexis information
for the investment community

built@zoomedia
You are now leaving this website. If you would like to continue, click Continue.
CancelContinue